HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $437,957 | +52.4% | 4,889 | +40.8% | 0.00% | +100.0% |
Q1 2023 | $287,308 | -35.9% | 3,472 | -39.1% | 0.00% | -50.0% |
Q4 2022 | $448,305 | -43.5% | 5,700 | -46.8% | 0.00% | -33.3% |
Q3 2022 | $793,000 | -42.5% | 10,718 | -58.8% | 0.00% | 0.0% |
Q4 2021 | $1,379,000 | -65.5% | 25,998 | -54.1% | 0.00% | -66.7% |
Q3 2021 | $4,002,000 | +11.4% | 56,692 | +5.1% | 0.01% | 0.0% |
Q2 2021 | $3,594,000 | -59.3% | 53,928 | -27.5% | 0.01% | -50.0% |
Q4 2020 | $8,835,000 | -9.3% | 74,400 | -33.4% | 0.02% | -28.0% |
Q3 2020 | $9,742,000 | +106.0% | 111,657 | +111.4% | 0.02% | +56.2% |
Q2 2020 | $4,730,000 | +166.5% | 52,815 | +196.5% | 0.02% | +60.0% |
Q1 2020 | $1,775,000 | -37.8% | 17,811 | -21.3% | 0.01% | -44.4% |
Q3 2019 | $2,853,000 | +120.5% | 22,619 | +110.3% | 0.02% | +100.0% |
Q2 2019 | $1,294,000 | +372.3% | 10,756 | +243.4% | 0.01% | +350.0% |
Q1 2019 | $274,000 | -84.1% | 3,132 | -81.8% | 0.00% | -81.8% |
Q4 2018 | $1,722,000 | -33.5% | 17,205 | -23.9% | 0.01% | -8.3% |
Q3 2018 | $2,590,000 | – | 22,602 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |